Biological Activity of Soybean Hydrolyzed Protein Conjugated with Mannose and Allulose

Practical Impact

Rare sugars just got more useful. A 2024 study published in Foods (DOI: 10.3390/foods13193041) shows that conjugating soybean protein hydrolysates with allulose and mannose through the Maillard reaction produces peptides with serious biological potential. For formulators, this is not just another antioxidant story. The conjugated product demonstrates enzyme inhibition that could support weight management claims.

Background

Non-enzymatic conjugation of peptides via the Maillard reaction has gained traction in food science. The process is simple. Heat proteins with reducing sugars. The resulting complexes often show enhanced bioactivity compared to the starting materials. Most research has focused on common sugars like glucose and fructose. Rare sugars remain under-explored, even though they bring their own metabolic benefits to the table.

This study zeroes in on allulose and mannose. Both are low-calorie sweeteners with functional properties. Allulose, in particular, has drawn heavy interest from the food industry. Pairing these sugars with soy protein hydrolysate opens up new formulation possibilities.

What the Study Did

The researchers created a conjugate called SPHA. That stands for soybean protein hydrolysate combined with allulose. They also tested a mannose version. Both went through controlled Maillard reaction conditions. The goal was to measure three specific biological activities. First, antioxidant capacity using DPPH radical scavenging and FRAP assays. Second, pancreatic lipase inhibition, which matters for fat absorption and weight control. Third, ACE inhibition, which is relevant for blood pressure management.

Each test compared the conjugates against the rare sugars alone and the unmodified protein hydrolysate.

Key Findings

The numbers are striking. SPHA hit a DPPH radical scavenging activity of 280.87 ± 16.39 µg Trolox/mL. That is strong. Its FRAP value came in at 38.91 ± 0.02 mg Trolox/mL. Both indicate robust antioxidant power. Your ingredient shelf just got a new candidate for oxidative stability.

Pancreatic lipase inhibition for SPHA reached 29.43 ± 1.94%. That positions it as a mild functional ingredient for weight management products. It will not replace prescription drugs, but it does not need to. For a food ingredient, this level of enzyme inhibition adds a legitimate functional claim.

ACE inhibition deserves attention too. Both the conjugated mixtures and the rare sugars themselves showed ACE inhibitory properties. That means allulose and mannose contribute directly. Formulators do not need to rely solely on the peptide portion. The sugar does some of the work.

Sample	DPPH Radical Scavenging	FRAP Value	Lipase Inhibition	ACE Inhibition
SPHA (allulose conjugate)	280.87 ± 16.39 µg Trolox/mL	38.91 ± 0.02 mg Trolox/mL	29.43 ± 1.94%	Present
Unmodified soy hydrolysate	Baseline	Baseline	Not reported	Not reported
Rare sugars alone	Not reported	Not reported	Not reported	Present

The table tells a clear story. The allulose conjugate outperforms on the key metrics measured. The unmodified hydrolysate serves as the baseline comparison. Rare sugars bring their own ACE activity to the mix.

What It Means for Manufacturers

You have a new tool for functional food development. The antioxidant capacity of SPHA is especially relevant for products prone to lipid oxidation. Think meat analogues, sauces, dressings, and nutritional bars. Adding this conjugate could extend shelf life while delivering a clean label.

The lipase inhibition opens doors for weight management positioning. A protein-based ingredient with mild fat-blocking activity fits well into meal replacements, protein shakes, and functional snacks. Allulose already has a following in the low-sugar space. This adds another reason to use it.

Consider the ACE inhibition angle. This is a niche but growing category. Heart health products often rely on synthetic peptides or plant extracts. A soy-allulose conjugate gives you a familiar base with a functional twist. The fact that the sugars themselves contribute means you get activity even if the conjugation degree varies between batches.

One practical note. The Maillard reaction requires heat and time. Your processing parameters will affect the final bioactivity. Test your specific production conditions. The study used controlled laboratory settings, so scale-up will need validation. Also be aware of color and flavor changes. The Maillard reaction inevitably darkens the product and introduces roasted notes. That works fine for certain applications but could be a hurdle in white or neutral-colored products.

FAQ

Does this work with any soy protein? The study used a hydrolyzed form. That matters. Hydrolysis exposes reactive amino groups that participate in the Maillard reaction. Intact soy protein will behave differently. If you plan to use soy protein isolate or concentrate, expect different results. Run your own trials.

Is allulose just a carrier here? No. The rare sugars showed ACE inhibition on their own. They are active participants, not passive carriers. That is a meaningful finding for ingredient buyers. You get the functional benefits of allulose and the peptide activity in one system.

What about cost? Rare sugars cost more than standard sugars. But the functional benefits justify the premium in targeted applications. For antioxidant protection and lipase inhibition, this conjugate could replace multiple ingredients. If you currently blend a synthetic antioxidant and a lipase inhibitor, switching to SPHA may simplify your label and your supply chain.

The study adds real science to the allulose value proposition. Soy protein hydrolysate and allulose, together, do more than either could alone. The Maillard conjugation is straightforward, the raw materials are familiar, and the bioactivities are measurable. For food formulators looking to differentiate their products, this is a practical route forward. Read the full paper for the raw data and then design your own validation trials. The groundwork is solid.